Tomorrow Health secures $60M investment

NEW YORK – Tomorrow Health has closed a $60 million Series B round of funding to expand partnerships and its footprint. 

The company’s total funding to date is now $92.5 million, with this most recent round led by BOND, with participation from Andreessen Horowitz, Obvious Ventures, BoxGroup, and Sound Ventures.  

“For patients navigating the transition home from surgery or managing a chronic condition, lack of access to critical medical equipment, supplies and services can lead to catastrophic outcomes for their care,” said Vijay Kedar, co-founder and CEO of Tomorrow Health. “At Tomorrow Health, we endeavor to restore the home as the patient's primary place of care by seamlessly coordinating the resources they need to heal at home.” 

Tomorrow Health offers a technology and analytics platform to help providers operate their businesses efficiently, deliver high quality care and succeed in a changing reimbursement and policy landscape. The platform covers millions of Americans through partnerships with insurers and home-based care suppliers, leveraging a national footprint that encompasses tens of thousands of providers and hospital systems. 

The company is accelerating to 317% annual recurring revenue (ARR) growth year-over-year from 2021 to 2022, as one in four Americans seek care at home. 

“Home-based health care represents a $195 billion market opportunity,” said BOND General Partner Noah Knauf. “Labor shortages, demographic shifts and evolving patient preferences are helping fuel demand for high-quality home-based care. Tomorrow Health has the team, technology, and deep industry expertise to make quality care at home – and at scale – a reality. Countless patients are already experiencing the value that Tomorrow Health has brought to market.”